iDREAM team / Presentation

Imaging, Development, Repair or REAdaptation, Motor plasticity

Pathologies: Stroke, Post-traumatic Stress Disorder, Traumatic Brain Injury, Cerebral Palsy, Developmental pathologies

Team leader: Isabelle Loubinoux

co-team leader: David Amarantini


Located at Purpan Hospital, the unit owns a Philips 3T MRI, high density EEG, TMS, tDCS, tACS, Movement laboratory with a Biodex, EEG, EMG, and a safety Level2 cell culture laboratory, a 3D printing laboratory. It has access to the Primate and Rodent animal facilities and to a µIRM scanner (CREFRE).

Therapeutic projects are based on brain stimulation tools and techniques promoting post-injury brain plasticity.

Scientific objectives

All the themes of the iDREAM team share a common focus : understanding the cognitive-motor functions involved in dayly life activities,

through methodological tools for functional exploration, NeuroImaging and NeuroBiomechanics.

We explore therapeutic strategies that will have a major impact on future clinical treatments for acute brain injury and dysfunctions especially in severely disabled patients.

We are driven by a cross-disciplinary and multidisciplinary approach.

We explore the movement from the expert and the healthy individual to the patient.

We observe from the neurocellular level to the behavioral level, encompassing the neurological, muscular, psychological, and social levels.

Our research adopts a translational approach, combining fundamental questions with practical applications.


Our research axes

The axes explore two types of brain plasticity processes: repair and readaptation.

The team includes scientists in NeuroImaging, Biomechanics and Cell Biology and clinicians in Neurology, Neurorehabilitation, Neurophysiology, Neurosurgery, and Psychiatry.


Our expertises


Our technical skills

The group’s expertise is highly translational since it ranges from cells, rodents, non-human primates, healthy subjects and patients.


Therapeuties


Our projects must determine the therapeutic strategies that will have a major impact on future clinical treatments for acute brain injury and dysfunctions specifically in severely disabled patients.

They are based on the natural plasticity of the brain and endogenous neurogenesis, and they seek to amplify it by external agents, rehabilitation, non-invasive stimulation, non-pharmacological interventions, drugs, regenerative implants, cellular therapy, neuroprosthesis for prehension allowing functional suppleance.

They also aim to determine the cerebral substrates of these interventions by neuroimaging.

Historically, the team studied Stroke. The leading cause of disability, stroke represents a significant economic cost. Hemiplegia and hemiparesia are the most common deficits. The main result of our previous work is to promote ipsilesional activity.

Them, the team expanded and became more broadly interested in motor disorders such as cerebral palsy, coordination disorders (dyspraxia), neurodevelopmental disorders, and dystonias.

The second generation of regenerative implants focuses on biodegradable implants. 3D printing gives them a comlpex architecture mimicking the cerebral cortex in six interconnected layers.